These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10653307)

  • 1. Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration.
    Laureys S; Salmon E; Garraux G; Peigneux P; Lemaire C; Degueldre C; Franck G
    J Neurol; 1999 Dec; 246(12):1151-8. PubMed ID: 10653307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration.
    Nagasawa H; Tanji H; Nomura H; Saito H; Itoyama Y; Kimura I; Tuji S; Fujiwara T; Iwata R; Itoh M; Ido T
    J Neurol Sci; 1996 Aug; 139(2):210-7. PubMed ID: 8856655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
    Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
    Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
    Thobois S; Guillouet S; Broussolle E
    Neurophysiol Clin; 2001 Oct; 31(5):321-40. PubMed ID: 11817273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies.
    Eidelberg D; Moeller JR; Dhawan V; Sidtis JJ; Ginos JZ; Strother SC; Cedarbaum J; Greene P; Fahn S; Rottenberg DA
    Mov Disord; 1990; 5(3):203-13. PubMed ID: 2117706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease.
    Brück A; Aalto S; Nurmi E; Bergman J; Rinne JO
    Neurobiol Aging; 2005 Jun; 26(6):891-8. PubMed ID: 15718048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies.
    Nagano-Saito A; Kato T; Arahata Y; Washimi Y; Nakamura A; Abe Y; Yamada T; Iwai K; Hatano K; Kawasumi Y; Kachi T; Dagher A; Ito K
    Neuroimage; 2004 Jun; 22(2):553-61. PubMed ID: 15193583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemispheric Network Expression in Parkinson's Disease: Relationship to Dopaminergic Asymmetries.
    Tang CC; Holtbernd F; Ma Y; Spetsieris P; Oh A; Fink GR; Timmermann L; Eggers C; Eidelberg D
    J Parkinsons Dis; 2020; 10(4):1737-1749. PubMed ID: 32925097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease.
    Kaasinen V; Maguire RP; Hundemer HP; Leenders KL
    J Neurol; 2006 Mar; 253(3):340-8. PubMed ID: 16222426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms.
    Kumakura Y; Gjedde A; Danielsen EH; Christensen S; Cumming P
    J Cereb Blood Flow Metab; 2006 Mar; 26(3):358-70. PubMed ID: 16079784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic topography of the hemiparkinsonism-hemiatrophy syndrome.
    Przedborski S; Giladi N; Takikawa S; Ishikawa T; Dhawan V; Spetsieris P; Chaly T; Fahn S; Eidelberg D
    Neurology; 1994 Sep; 44(9):1622-8. PubMed ID: 7936286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal dopa and glucose metabolism in PD patients with freezing of gait.
    Bartels AL; de Jong BM; Giladi N; Schaafsma JD; Maguire RP; Veenma L; Pruim J; Balash Y; Youdim MB; Leenders KL
    Mov Disord; 2006 Sep; 21(9):1326-32. PubMed ID: 16721756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary parkinsonism due to focal substantia nigra lesions: a PET study with [18F]FDG and [18F]fluorodopa.
    Boecker H; Weindl A; Leenders K; Antonini A; Kuwert T; Kruggel F; Grafin von Einsiedel H; Conrad B
    Acta Neurol Scand; 1996 Jun; 93(6):387-92. PubMed ID: 8836298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.
    Huang WS; Chiang YH; Lin JC; Chou YH; Cheng CY; Liu RS
    J Nucl Med; 2003 Jul; 44(7):999-1005. PubMed ID: 12843212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease.
    Antonini A; Leenders KL; Vontobel P; Maguire RP; Missimer J; Psylla M; Günther I
    Brain; 1997 Dec; 120 ( Pt 12)():2187-95. PubMed ID: 9448574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of glucose metabolism in corticobasal degeneration.
    Taniwaki T; Yamada T; Yoshida T; Sasaki M; Kuwabara Y; Nakagawa M; Mihara F; Motomura S; Shigetou H; Kira J
    J Neurol Sci; 1998 Nov; 161(1):70-6. PubMed ID: 9879684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography in degenerative disorders of the dopaminergic system.
    Karbe H; Holthoff V; Huber M; Herholz K; Wienhard K; Wagner R; Heiss WD
    J Neural Transm Park Dis Dement Sect; 1992; 4(2):121-30. PubMed ID: 1571076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG.
    Otsuka M; Kuwabara Y; Ichiya Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Kato M; Masuda K
    Ann Nucl Med; 1997 Aug; 11(3):251-7. PubMed ID: 9310175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET.
    Berding G; Odin P; Brooks DJ; Nikkhah G; Matthies C; Peschel T; Shing M; Kolbe H; van Den Hoff J; Fricke H; Dengler R; Samii M; Knapp WH
    Mov Disord; 2001 Nov; 16(6):1014-22. PubMed ID: 11748732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Three cases of clinically diagnosed corticobasal degeneration--neuroimaging studies with MRI, SPECT and PET].
    Koide T; Hozumi I; Souma Y; Nagasawa H; Tuji S
    Rinsho Shinkeigaku; 1995 Nov; 35(11):1184-90. PubMed ID: 8720326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.